Navin Fluorine International Share: Pros and Cons Every Investor Must Know in 2026

Current Navin Fluorine International share price: Navin Fluorine International share CMP approx Rs 8,330. 52-week high Rs 11,000, low Rs 7,000. Market Cap Rs 44,352 Cr. P/E ratio 56.16x.

Is the Navin Fluorine International share International share a good investment in 2026? This article provides a data-driven analysis of Navin Fluorine International share pros and cons — covering business strengths, valuation, growth drivers, and key risks — based on live data from 7 August 2026.

Click Here — Get Free Investment Predictions

About Navin Fluorine International

Navin Fluorine International share International Limited (NSE: NAVINFLUOR) is a Surat-based specialty fluorine chemistry company founded in 1967. India’s premier fluorochemical company, it manufactures Hydrofluorocarbons (HFCs — refrigerants), High Performance Products (specialty fluorinating agents for agrochemicals, pharmaceuticals), and CRAMS (Contract Research and Manufacturing Services) — providing bespoke fluorine chemistry synthesis services to global pharmaceutical companies. Navin Fluorine is a leader in challenging fluorination chemistry that requires exceptional process safety expertise.

Key Financial Snapshot: Navin Fluorine International Share

Parameter	Details
Company	Navin Fluorine International
NSE Symbol	NAVINFLUOR
Sector	Fluorochemicals Specialty
CMP (Approx)	Rs 8,330
52-Week High	Rs 11,000
52-Week Low	Rs 7,000
Market Cap	Rs 44,352 Cr
P/E Ratio	56.16x

Data approximate. Verify at nseindia.com.

Top 5 Pros of Navin Fluorine International Share

1. India’s Dominant Fluorine Chemistry Company — Process Safety Moat in Specialty Chemicals

Navin Fluorine share represents India’s most technically specialised fluorine chemistry company. Fluorination chemistry involves handling highly toxic and corrosive hydrofluoric acid (HF) and other reactive fluorinating agents under extreme process safety conditions — capabilities that require decades of process engineering investment that cannot be quickly replicated by new entrants.

2. CRAMS Business — Long-Term Pharma Partner Revenue With Multi-Year Contracts

Navin’s CRAMS segment provides bespoke fluorine synthesis services for global pharmaceutical companies developing fluorinated drug molecules (fluorine is present in approximately 30 percent of new pharmaceutical compounds). These CRAMS contracts provide multi-year revenue visibility with sticky relationships that pharmaceutical partners do not easily switch.

3. HFC Refrigerant Business — Transition to Next-Gen HFO Refrigerants Growing Market

While HFC refrigerants face phase-down under the Kigali Amendment, Navin Fluorine is positioned in next-generation HFO (Hydrofluoroolefin) refrigerants — lower global warming potential alternatives that will replace HFCs in air conditioners and refrigeration systems globally.

4. 16.69% ROE With Moderate Debt — Quality Fluorine Chemistry Returns

At 16.69% ROE with debt-to-equity of 0.32x, Navin Fluorine delivers quality returns for a capital-intensive specialty chemical company requiring significant investment in explosion-proof manufacturing infrastructure and process safety systems.

5. Specialty Agrochemical Fluorination — Growing Crop Protection Chemistry Demand

Global agrochemical companies are increasingly developing fluorinated crop protection molecules with superior efficacy and lower environmental persistence. Navin Fluorine’s specialty fluorination capabilities position it as a preferred synthesis partner for these next-generation agrochemical intermediates.

Key Cons of Navin Fluorine International Share

1. PE of 56.16x Is Premium — Requires CRAMS Revenue Growth to Justify

At 56.16x PE, Navin Fluorine share prices in strong CRAMS revenue growth from long-term pharma contracts and HFO refrigerant market share gain. Any CRAMS partner delay or HFO technology adoption slowdown compresses the multiple.

2. CRAMS Customer Concentration — Revenue From a Few Large Pharma Partnerships

Navin Fluorine’s CRAMS business revenue is concentrated in a small number of large global pharmaceutical partnerships. If any major CRAMS partner reduces order volumes — from drug development failure, pipeline change, or competitor switching — it creates material revenue impact.

3. HFC Phase-Down Under Kigali Amendment — Refrigerant Revenue Transitioning

The global Kigali Amendment to the Montreal Protocol mandates phase-down of HFC refrigerants with high global warming potential. While Navin is transitioning toward HFOs, the HFC phase-down creates near-term volume uncertainty in its refrigerant segment.

4. Process Safety Incident Risk — Fluorine Chemistry Inherent Hazard

Fluorine chemistry inherently carries explosion, fire, and toxic release risks from handling hydrofluoric acid and other reactive fluorinating reagents. Any process safety incident at Navin Fluorine’s manufacturing facility would have severe human, environmental, regulatory, and business continuity consequences.

Use the Univest Screener to Analyse Stocks for Free

Is Navin Fluorine International Share a Good Investment in 2026?

Navin Fluorine International share analysis summary:

The Navin Fluorine International share is India’s premier specialty fluorine chemistry investment. Investors evaluating Navin Fluorine International share should prioritise CRAMS revenue growth and HFO refrigerant adoption as the two primary earnings catalysts. The Navin Fluorine International share at 56.16x PE requires sustained CRAMS pharma partner growth. Research Navin Fluorine International share on the Univest Screener for detailed specialty chemical sector analysis.

Navin Fluorine share is India’s premier fluorine chemistry investment at premium PE. The CRAMS moat and technical process safety expertise are genuine differentiators. CRAMS customer concentration and the PE requiring growth delivery are the key constraints. Consider as quality specialty chemical CDMO allocation.

Key Risks Before Buying Navin Fluorine International share

• Major CRAMS pharma partner reducing Navin Fluorine contract volumes from drug pipeline change
• HFC refrigerant phase-down accelerating faster than HFO ramp-up creating refrigerant revenue gap
• Process safety incident at Navin’s plant causing production disruption and regulatory action
• Chinese fluorine chemistry companies building bespoke synthesis capacity to compete in CRAMS

Conclusion

The Navin Fluorine International share is worth analysing for portfolio inclusion. The Navin Fluorine International share offers india’s dominant fluorine chemistry company — process safety moat in specialty chemicals as its primary investment case. Weigh it against pe of 56.16x is premium — requires crams revenue growth to justify and the risks above before investing. Use the Univest Screener and consult a SEBI-registered advisor.

Download the Univest iOS App or Univest Android App to track Navin Fluorine International share price live.

Frequently Asked Questions — Navin Fluorine International Share

What are the main pros of Navin Fluorine share?

Ans. Navin Fluorine International share international share analysis: India’s dominant fluorine chemistry company with process safety moat, CRAMS long-term pharma partner revenue with multi-year contracts, HFO next-gen refrigerant positioning, 16.69% ROE with moderate debt, and specialty agrochemical fluorination growing from next-gen crop protection demand.

What are the risks of Navin Fluorine share?

Ans. Navin Fluorine International share international share analysis: PE of 56.16x requiring CRAMS growth delivery, CRAMS customer concentration in a few large pharma partners, HFC refrigerant phase-down creating transition uncertainty, and inherent process safety risk from fluorine chemistry. Monitor quarterly CRAMS order book and HFO revenue growth.

Is Navin Fluorine share a good investment?

Ans. Navin Fluorine International share international share analysis: India’s premier fluorine chemistry at premium PE. Consider as quality specialty chemical CDMO allocation. Consult a SEBI-registered advisor. Not investment advice.

What is the 52-week range of Navin Fluorine share?

Ans. Navin Fluorine International share international share analysis: 52-week high approximately Rs 11,000, low Rs 7,000. Note: down 3.7% today. Verify at nseindia.com.

What is CRAMS in specialty chemicals?

Ans. Navin Fluorine International share international share analysis: CRAMS (Contract Research and Manufacturing Services) involves a pharmaceutical company outsourcing the synthesis of specific drug intermediates or active pharmaceutical ingredients to a specialist manufacturer like Navin Fluorine. The pharmaceutical company provides the synthesis route; Navin Fluorine provides the specialised fluorine chemistry expertise, equipment, and process safety infrastructure to manufacture the molecule at commercial scale. CRAMS relationships are typically multi-year exclusive contracts because switching suppliers for regulated pharmaceutical intermediates requires expensive FDA re-validation.

Why is fluorine chemistry so specialised and hard to replicate?

Ans. Navin Fluorine International share international share analysis: Fluorine is the most reactive element on the periodic table. Fluorinating agents (hydrofluoric acid, sulfur tetrafluoride, elemental fluorine) are highly corrosive, toxic, and potentially explosive. Manufacturing facilities require Hastelloy (corrosion-resistant alloy) reactors, specialised scrubbers to neutralise HF emissions, explosion-proof electrical systems, and personnel trained in chemical emergency response. Building this infrastructure safely takes 5 to 10 years and significant capital — creating the process safety moat that makes Navin Fluorine’s capabilities extremely difficult for new competitors to replicate quickly.